Critical role of TCF-1 on the epigenetic identity of memory T cells
Critical role of TCF-1 on the epigenetic identity of memory T cells
批准号:
10549303
负责人:
Golnaz Vahedi
金额:
$45.17万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-15 至 2024-12-31
关键词:
3-DimensionalAdaptive Immune SystemAreaBindingBinding SitesBiological AssayCD8-Positive T-LymphocytesCell physiologyCellsChromatinCollaborationsCombined Modality TherapyConsensusDataDevelopmentDiseaseEffector CellEpigenetic ProcessEventFOXO1A geneFlow CytometryFoundationsGene Expression ProfileGenerationsGenesGenomeGenomic SegmentGoalsIn VitroInfectionMachine LearningMapsMediatingMemoryMolecularMonitorOrgan TransplantationOutcomePeripheralProteinsRegulatory ElementResearchResolutionRoleSiteT cell differentiationT cell responseT memory cellT-Cell ActivationT-Cell DevelopmentT-LymphocyteTCF Transcription FactorTechniquesTertiary Protein StructureTestingThymus GlandTranslatingcell typechronic infectionepigenomeepigenomicsimmunoregulationin vivomembermutantnovelnovel therapeutic interventionpathogenpermissivenesssynergismtooltranscription factortranscriptomics
中文摘要
本研究的目的是研究转录因子TCF-1在决定表观遗传身份中的作用
英文摘要
The goal of this proposal is to study the role of transcription factor TCF-1 in determining the epigenetic identity
of memory CD8+ T cells. Our adaptive immune system has evolved a unique capacity to remember a pathogen
through the generation of memory T cells, which protect the host in the event of reinfection. A better
understanding of memory T cell differentiation is crucial for developing strategies to limit T cell responses in
organ transplantation or enhance T cell responses during chronic infections. Although it is known that the
transcription factor TCF-1 is required for memory CD8+ T cell function, the mechanisms through which this
protein controls memory T cell fate remain unclear. Recently, we discovered that a mechanism through which
TCF-1 controls the development of T cells relates to its unprecedented ability to create the chromatin
accessibility landscape of naïve T cells. We found that TCF-1 is selectively enriched at genomic regions that
become accessible at the earliest stages of development and is required for the accessibility of these
regulatory elements. At the single-cell level, TCF-1 can dictate a coordinate opening of chromatin in T cells.
Moreover, ectopic TCF-1 can directly erase repressive chromatin marks in non-T cells, generating de novo
open chromatin and inducing the expression of T cell genes. While our recent data determined the novel role
of TCF-1 on the epigenome during T cell development, our findings also raised another critical question: what
is the role of TCF-1 on the epigenetic identity of memory T cells? We hypothesize that TCF-1 in cooperation
with transcription factor partners defines the epigenetic landscape of memory T cells. Our new preliminary data
further indicate that TCF-1 expression post T cell activation in vitro can lead to gains in chromatin accessibility
at pro-memory genes. However, it remains unclear if TCF-1 expression in T cells responding to an infection
can create the epigenetic identity of memory T cells. The domains of TCF-1 required for targeting the
chromatin and its potential cooperating factors also remain unknown. How TCF-1 dependent changes on the
epigenome relate to pro-memory genes needs to be defined. To answer these questions, we will interrogate
the effect of TCF-1 and its potential partners on the chromatin state and accessibility of CD8+ T cells in vitro.
Using the state-of-the-art tools, we will generate the map of TCF-1 dependent 3D genome organization and
define how changes on the epigenome relate to memory genes. We will further translate these findings in vivo
exploiting single-cell epigenomic, transcriptomic, and flow cytometry assays. The expected outcome of this
proposal is a detailed understanding of the fundamental interaction between TCF-1 and the chromatin in
peripheral T cells which can be exploited to devise combination therapies including epigenetic editing to
selectively alter T cell fate at will.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1111/imr.12942
发表时间:
2021-03
期刊:
Immunological reviews
影响因子:
8.7
作者:
[Vahedi G]
通讯作者:
Vahedi G
DOI:
10.1038/s41590-022-01232-z
发表时间:
2022-07
期刊:
NATURE IMMUNOLOGY
影响因子:
30.5
作者:
[Wang, Wenliang, Chandra, Aditi, Goldman, Naomi, Yoon, Sora, Ferrari, Emily K., Nguyen, Son. C., Joyce, Eric F., Vahedi, Golnaz]
通讯作者:
Vahedi, Golnaz
DOI:
10.3389/fgene.2018.00319
发表时间:
2018
期刊:
Frontiers in genetics
影响因子:
3.7
作者:
[Cai S, Georgakilas GK, Johnson JL, Vahedi G]
通讯作者:
Vahedi G
DOI:
10.1038/s41467-022-29258-9
发表时间:
2022-03-24
期刊:
Nature communications
影响因子:
16.6
作者:
[Yoon S, Chandra A, Vahedi G]
通讯作者:
Vahedi G
DOI:
10.1038/s41592-019-0509-5
发表时间:
2019-09-01
期刊:
NATURE METHODS
影响因子:
48
作者:
[Choobdar, Sarvenaz, Ahsen, Mehmet E., Marbach, Daniel]
通讯作者:
Marbach, Daniel
Dissecting transcriptomics and epigenomic signatures of immune cells in type 1 diabetes
-
批准号:10829819
-
项目类别:
-
资助金额:$50.09万
-
财政年份:2020
-
负责人:Golnaz Vahedi
-
依托单位:
Dissecting transcriptomics and epigenomic signatures of immune cells in type 1 diabetes
-
批准号:10262966
-
项目类别:
-
资助金额:$51.73万
-
财政年份:2020
-
负责人:Golnaz Vahedi
-
依托单位:
Dissecting transcriptomics and epigenomic signatures of immune cells in type 1 diabetes
-
批准号:10658838
-
项目类别:
-
资助金额:$51.07万
-
财政年份:2020
-
负责人:Golnaz Vahedi
-
依托单位:
Critical role of TCF-1 on the epigenetic identity of memory T cells
-
批准号:10087956
-
项目类别:
-
资助金额:$45.17万
-
财政年份:2019
-
负责人:Golnaz Vahedi
-
依托单位:
Critical role of TCF-1 on the epigenetic identity of memory T cells
-
批准号:10320935
-
项目类别:
-
资助金额:$45.17万
-
财政年份:2019
-
负责人:Golnaz Vahedi
-
依托单位:
Super-enhancer structure defines a signature of inflammatory bowel disease (IBD)
-
批准号:8749475
-
项目类别:
-
资助金额:$16.12万
-
财政年份:2015
-
负责人:Golnaz Vahedi
-
依托单位:
海外基金